As a third-generation paclitaxel drug, albumin-bound paclitaxel uses nanotechnology to make albumin and paclitaxel into nanoparticles, and achieves the realization of the targeting function of chemotherapeutic drugs, and secondly, albumin-bound paclitaxel does not require solvent to dissolve, reducing the incidence of allergic reactions.[20,21] These 2 characteristics make it widely used in the treatment of malignant tumors. Here, ALB is linked to cancer.